Rigel Pharmaceuticals, Inc. (RIGL)
47.15
+0.18
(+0.38%)
USD |
NASDAQ |
Oct 02, 16:00
47.12
-0.03
(-0.06%)
After-Hours: 20:00
Rigel Pharmaceuticals Market Cap : 879.53M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 879.53M |
| October 01, 2026 | 876.17M |
| September 30, 2026 | 898.19M |
| September 29, 2026 | 911.99M |
| September 28, 2026 | 920.76M |
| September 25, 2026 | 898.74M |
| September 24, 2026 | 893.34M |
| September 23, 2026 | 897.81M |
| September 22, 2026 | 910.68M |
| September 21, 2026 | 878.41M |
| September 18, 2026 | 870.02M |
| September 17, 2026 | 855.28M |
| September 16, 2026 | 829.73M |
| September 15, 2026 | 827.49M |
| September 14, 2026 | 845.95M |
| September 11, 2026 | 881.21M |
| September 10, 2026 | 881.96M |
| September 09, 2026 | 880.84M |
| September 08, 2026 | 883.64M |
| September 04, 2026 | 907.89M |
| September 03, 2026 | 904.71M |
| September 02, 2026 | 921.88M |
| September 01, 2026 | 886.06M |
| August 31, 2026 | 861.44M |
| August 28, 2026 | 867.03M |
| Date | Value |
|---|---|
| August 27, 2026 | 874.12M |
| August 26, 2026 | 867.03M |
| August 25, 2026 | 872.07M |
| August 24, 2026 | 841.48M |
| August 21, 2026 | 856.03M |
| August 20, 2026 | 844.09M |
| August 19, 2026 | 875.99M |
| August 18, 2026 | 813.68M |
| August 17, 2026 | 791.86M |
| August 14, 2026 | 794.28M |
| August 13, 2026 | 760.89M |
| August 12, 2026 | 781.04M |
| August 11, 2026 | 783.84M |
| August 10, 2026 | 777.12M |
| August 07, 2026 | 749.33M |
| August 06, 2026 | 731.61M |
| August 05, 2026 | 755.11M |
| August 04, 2026 | 721.91M |
| August 03, 2026 | 698.22M |
| July 31, 2026 | 680.31M |
| July 30, 2026 | 703.41M |
| July 29, 2026 | 722.08M |
| July 28, 2026 | 711.54M |
| July 27, 2026 | 691.03M |
| July 24, 2026 | 679.01M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cytokinetics, Inc. | 9.103B |
| Ironwood Pharmaceuticals, Inc. | 601.47M |
| Capricor Therapeutics, Inc. | 520.08M |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
Market Cap Related Metrics
| PE Ratio | 2.889 |
| PS Ratio | 3.331 |
| PEG Ratio | 0.0143 |
| Price to Book Value | 2.067 |
| Price to Free Cash Flow | 101.95 |
| Price | 47.15 |
| Earnings Yield | 34.62% |
| PEGY Ratio | 0.0143 |
| Operating PE Ratio | 10.59 |
| Normalized PE Ratio | 2.887 |